Home Cart 0 Sign in  
X

[ CAS No. 371-41-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 371-41-5
Chemical Structure| 371-41-5
Chemical Structure| 371-41-5
Structure of 371-41-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 371-41-5 ]

Related Doc. of [ 371-41-5 ]

Alternatived Products of [ 371-41-5 ]

Product Details of [ 371-41-5 ]

CAS No. :371-41-5 MDL No. :MFCD00002316
Formula : C6H5FO Boiling Point : -
Linear Structure Formula :- InChI Key :RHMPLDJJXGPMEX-UHFFFAOYSA-N
M.W : 112.10 Pubchem ID :9732
Synonyms :

Calculated chemistry of [ 371-41-5 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 28.42
TPSA : 20.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.36
Log Po/w (XLOGP3) : 1.77
Log Po/w (WLOGP) : 1.95
Log Po/w (MLOGP) : 1.9
Log Po/w (SILICOS-IT) : 1.84
Consensus Log Po/w : 1.76

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.21
Solubility : 0.699 mg/ml ; 0.00624 mol/l
Class : Soluble
Log S (Ali) : -1.81
Solubility : 1.73 mg/ml ; 0.0154 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.04
Solubility : 1.02 mg/ml ; 0.0091 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 371-41-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 371-41-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 371-41-5 ]
  • Downstream synthetic route of [ 371-41-5 ]

[ 371-41-5 ] Synthesis Path-Upstream   1~54

  • 1
  • [ 371-41-5 ]
  • [ 701-16-6 ]
Reference: [1] International Journal of Mass Spectrometry, 2013, vol. 345-347, p. 120 - 131
  • 2
  • [ 371-41-5 ]
  • [ 13451-79-1 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 16, p. 4838 - 4842
  • 3
  • [ 371-41-5 ]
  • [ 24410-59-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 15, p. 3823 - 3842
[2] Journal of Medicinal Chemistry, 2004, vol. 47, # 7, p. 1609 - 1612
[3] Patent: US2012/225863, 2012, A1,
[4] Patent: WO2012/119046, 2012, A2,
[5] Patent: WO2015/42397, 2015, A1,
[6] Tetrahedron, 2015, vol. 71, # 29, p. 4835 - 4841
[7] European Journal of Organic Chemistry, 2016, vol. 2016, # 13, p. 2268 - 2273
[8] New Journal of Chemistry, 2016, vol. 40, # 8, p. 6564 - 6567
[9] Journal of the American Chemical Society, 2017, vol. 139, # 24, p. 8267 - 8276
  • 4
  • [ 371-41-5 ]
  • [ 141-82-2 ]
  • [ 1994-13-4 ]
Reference: [1] Chemical Biology and Drug Design, 2011, vol. 78, # 4, p. 580 - 586
  • 5
  • [ 371-41-5 ]
  • [ 1994-13-4 ]
Reference: [1] Tetrahedron Letters, 1996, vol. 37, # 10, p. 1551 - 1554
  • 6
  • [ 371-41-5 ]
  • [ 1996-41-4 ]
Reference: [1] ACS Catalysis, 2018, vol. 8, # 5, p. 4033 - 4043
[2] European Journal of Organic Chemistry, 2018, vol. 2018, # 4, p. 485 - 493
[3] Bulletin of the Chemical Society of Japan, 1964, vol. 37, p. 583 - 584
[4] Journal of the Indian Chemical Society, 2002, vol. 79, # 5, p. 420 - 425
[5] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 14, p. 3347 - 3351
[6] Journal of Heterocyclic Chemistry, 2010, vol. 47, # 1, p. 15 - 21
[7] Tetrahedron Letters, 2011, vol. 52, # 40, p. 5149 - 5152
[8] Tetrahedron, 2013, vol. 69, # 7, p. 1857 - 1871
  • 7
  • [ 371-41-5 ]
  • [ 32315-10-9 ]
  • [ 38377-38-7 ]
Reference: [1] Chemistry - A European Journal, 2013, vol. 19, # 42, p. 14047 - 14051
[2] Organic Letters, 2018, vol. 20, # 16, p. 4838 - 4842
  • 8
  • [ 371-41-5 ]
  • [ 503-38-8 ]
  • [ 38377-38-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 8, p. 1716 - 1727
  • 9
  • [ 371-41-5 ]
  • [ 42864-24-4 ]
  • [ 5724-56-1 ]
  • [ 394-33-2 ]
  • [ 52962-97-7 ]
  • [ 52911-59-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1983, p. 1003 - 1010
  • 10
  • [ 371-41-5 ]
  • [ 42864-24-4 ]
  • [ 5724-56-1 ]
  • [ 394-33-2 ]
  • [ 52962-97-7 ]
  • [ 52911-65-6 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1983, p. 1003 - 1010
  • 11
  • [ 371-41-5 ]
  • [ 67-66-3 ]
  • [ 347-54-6 ]
YieldReaction ConditionsOperation in experiment
22% With sodium hydroxide In ethanol; water at 70℃; for 18 h; Heating Example 82 3- [4- (3-hydroxy-4-methyl-phenoxy)-2-methyl-phenyl]-propionic acid ethyl ester Step A A solution of NaOH (78 g, 1950 mmol) in H20 (400 mL) is added to a solution of 4-fluorophenol (50 g, 446.43 mmol) in a mixture of H2O (200 mL) and EtOH (150 mL). After the mixture is warmed to 70°C, CHC13 (110 mL) is added dropwise (addition funnel, about 2 h), and the mixture is stirred at this temperature overnight (c. a. 16 h). It is allowed to reach r. t. and acidified with HCl (3M). The reaction is partitioned between brine and CH2Cl2, and the organic layer is dried, filtered and concentrated. The crude residue is flash chromatographed on Si02 (3percent EtOAc/hexanes) to afford 13.6 of the title compound (22percent, white solid).
21% With sodium hydroxide In ethanol; water at 70℃; Example 80
Synthesis of 5-fluoro-2-hydroxybenzaldehyde
To a solution of 4-fluorophenol (25 mg, 223 mmol) in a mixed solvent of ethanol (100 mL) and H2O (75 mL) was added NaOH aqueous solution (39 g, 970 mmol, in 200 mL H2O).
The resulted mixture was warmed up to 70° C. and added chloroform (55 mL, 691 mmol) dropwise during 2 h, and then the mixture was stirred at 70° C. for overnight.
The reaction was cooled down to room temperature and quenched by addition of hydrochloric acid (6 M, 100 mL), and then the mixture was extracted with DCM (250 mL*2).
The combined organic layer was washed with H2O and brine, dried over sodium sulfate and concentrated under vacuum.
The residue was purified by column chromatography on silica gel (petroleum ether:ethyl acetate=25:1) to afford 5-fluoro-2-hydroxybenzaldehyde (6.5 g, yield: 21percent) as a light yellow solid.
1H NMR (400 MHz, CDCl3): δ 10.01 (s, 1H), 9.88 (s, 1H), 7.26-7.32 (m, 2H), 7.00 (dd, J=4.0, 8.8 Hz, 1H).
Reference: [1] Journal of the American Chemical Society, 1998, vol. 120, # 33, p. 8340 - 8347
[2] Patent: WO2005/37763, 2005, A1, . Location in patent: Page/Page column 126
[3] Patent: US2017/37038, 2017, A1, . Location in patent: Paragraph 0372; 0373; 0374
[4] Journal of the American Chemical Society, 1946, vol. 68, p. 2502
[5] European Journal of Medicinal Chemistry, 1996, vol. 31, # 6, p. 449 - 460
  • 12
  • [ 50-00-0 ]
  • [ 371-41-5 ]
  • [ 347-54-6 ]
Reference: [1] Organic Syntheses, 2005, vol. 82, p. 64 - 68
[2] Organic and Biomolecular Chemistry, 2017, vol. 15, # 6, p. 1530 - 1536
[3] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1994, # 13, p. 1823 - 1832
[4] Tetrahedron Letters, 2005, vol. 46, # 19, p. 3357 - 3358
[5] Tetrahedron Letters, 2005, vol. 46, # 32, p. 5285 - 5287
[6] Journal of Medicinal Chemistry, 2000, vol. 43, # 24, p. 4701 - 4710
[7] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5591 - 5593
[8] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 6, p. 1939 - 1943
[9] Chemistry - A European Journal, 2017, vol. 23, # 68, p. 17195 - 17198
[10] Organic Letters, 2017, vol. 19, # 23, p. 6340 - 6343
  • 13
  • [ 371-41-5 ]
  • [ 76-05-1 ]
  • [ 347-54-6 ]
Reference: [1] Patent: WO2016/201168, 2016, A1, . Location in patent: Paragraph 0512; 0513
  • 14
  • [ 371-41-5 ]
  • [ 100-97-0 ]
  • [ 347-54-6 ]
Reference: [1] Chemical & Pharmaceutical Bulletin, 1983, vol. 31, # 5, p. 1751 - 1753
  • 15
  • [ 108-95-2 ]
  • [ 371-41-5 ]
  • [ 367-12-4 ]
  • [ 367-27-1 ]
YieldReaction ConditionsOperation in experiment
41 %Spectr. With Selectfluor; 1-(n-butyl)-3-methylimidazolium triflate In methanol at 80℃; for 5 h; Inert atmosphere General procedure: A mixture of phenol (20 mg), F‐TEDA‐BF4 (1.1 equivalents), IL(0‐15 equivalents) and the organic solvent (5 mL) was stirred for 5 h at various temperatures under an argo atmosphere (Tables 1‐5). The mixture was evaporated at a reduced pressure and analysed by 1H, 19F NMR assolution in CDCl3 or CDCl3‐DMSO‐d6. Cl2CHCHCl2 and PhCF3 were used as internal standards for peakintegration.
Reference: [1] Journal of the American Chemical Society, 1990, vol. 112, # 23, p. 8563 - 8575
[2] Tetrahedron Letters, 1986, vol. 27, # 37, p. 4465 - 4468
[3] Tetrahedron Letters, 1986, vol. 27, # 37, p. 4465 - 4468
[4] Journal of Organic Chemistry, 1998, vol. 63, # 10, p. 3379 - 3385
[5] Tetrahedron Letters, 1986, vol. 27, # 37, p. 4465 - 4468
[6] Journal of Organic Chemistry, 1998, vol. 63, # 10, p. 3379 - 3385
[7] Journal of Organic Chemistry, 1998, vol. 63, # 10, p. 3379 - 3385
[8] Russian Journal of Organic Chemistry, 2009, vol. 45, # 10, p. 1468 - 1473
[9] Arkivoc, 2017, vol. 2018, # 2, p. 60 - 71
  • 16
  • [ 108-95-2 ]
  • [ 371-41-5 ]
  • [ 367-12-4 ]
  • [ 367-27-1 ]
  • [ 28177-48-2 ]
Reference: [1] Patent: CN105753655, 2016, A, . Location in patent: Paragraph 0028; 0030; 0038; 0054-0058
  • 17
  • [ 540-36-3 ]
  • [ 371-41-5 ]
  • [ 367-27-1 ]
  • [ 2713-31-7 ]
  • [ 7664-39-3 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 32, p. 11321 - 11330
  • 18
  • [ 371-41-5 ]
  • [ 394-33-2 ]
YieldReaction ConditionsOperation in experiment
97% With silica supported Al(NO3)3*9H2O In acetone at 20℃; for 0.5 h; General procedure: To a solution of phenol (1 mmol) in acetone (5 mL) wasadded silica supported Al(NO3)3·9H2O (1 mmol) and theresulting mixture stirred at room temperature. After completionof the reaction, as indicated by TLC, the reaction masswas filtered and the residue (silica) was washed with ethylacetate (2 5 mL). The filtrate and the washing were collectivelyconcentrated under reduced pressure, and the crudecompound was purified by column chromatography oversilica gel (100-200 mesh) to afford the pure ortho-nitro phenol(95percent) and para- nitro phenol (3percent).
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1983, p. 75 - 82
[2] Synthetic Communications, 1997, vol. 27, # 19, p. 3301 - 3311
[3] Synlett, 2003, # 2, p. 191 - 194
[4] Synthetic Communications, 2005, vol. 35, # 2, p. 263 - 270
[5] Synthetic Communications, 1998, vol. 28, # 15, p. 2773 - 2781
[6] Mendeleev Communications, 2006, vol. 16, # 1, p. 41 - 42
[7] Letters in Organic Chemistry, 2015, vol. 12, # 2, p. 129 - 135
[8] Chinese Journal of Chemistry, 2011, vol. 29, # 4, p. 731 - 734
[9] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1983, p. 75 - 82
[10] Phosphorus, Sulfur and Silicon and the Related Elements, 2003, vol. 178, # 5, p. 1027 - 1035
[11] Synthetic Communications, 2003, vol. 33, # 5, p. 703 - 710
[12] Synthetic Communications, 1999, vol. 29, # 19, p. 3295 - 3302
[13] Tetrahedron, 2005, vol. 61, # 46, p. 10861 - 10867
[14] South African Journal of Chemistry, 2007, vol. 60, p. 109 - 112
[15] Turkish Journal of Chemistry, 2010, vol. 34, # 5, p. 753 - 759
[16] Chinese Chemical Letters, 2011, vol. 22, # 7, p. 827 - 830
[17] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2001, vol. 40, # 12, p. 1191 - 1195
[18] European Journal of Organic Chemistry, 2005, # 11, p. 2379 - 2384
[19] Synthetic Communications, 2008, vol. 38, # 19, p. 3366 - 3374
[20] Advanced Synthesis and Catalysis, 2003, vol. 345, # 11, p. 1197 - 1202
[21] Journal of Chemical Research - Part S, 2001, # 4, p. 140 - 142
[22] Chinese Chemical Letters, 2011, vol. 22, # 12, p. 1431 - 1434
[23] Bulletin des Societes Chimiques Belges, 1984, vol. 93, # 11, p. 961 - 972
[24] Phosphorus, Sulfur and Silicon and the Related Elements, 2003, vol. 178, # 9, p. 2019 - 2025
[25] Inorganic Chemistry, 2010, vol. 49, # 23, p. 11106 - 11117
[26] Molecules, 2001, vol. 6, # 7, p. 614 - 620
[27] Canadian Journal of Chemistry, 2009, vol. 87, # 8, p. 1144 - 1147
[28] Molecules, 2002, vol. 7, # 10, p. 734 - 742
[29] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1998, # 1, p. 1 - 6
[30] J. Gen. Chem. USSR (Engl. Transl.), 1975, vol. 45, p. 2372 - 2379[31] Zhurnal Obshchei Khimii, 1975, vol. 45, # 11, p. 2414 - 2422
[32] Synthetic Communications, 1989, vol. 19, # 1, 2, p. 233 - 238
[33] Recueil des Travaux Chimiques des Pays-Bas, 1916, vol. 35, p. 142[34] Chem. Zentralbl., 1913, vol. 84, # II, p. 760
[35] Patent: US5086062, 1992, A,
[36] Patent: US5149821, 1992, A,
[37] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 22, p. 6842 - 6851
[38] International Journal of Mass Spectrometry, 2013, vol. 345-347, p. 120 - 131
[39] Organic Process Research and Development, 2003, vol. 7, # 1, p. 95 - 97
[40] Bl. Acad. Belg., 1913, p. 265[41] Chem. Zentralbl., 1913, vol. 84, # II, p. 760
  • 19
  • [ 540-80-7 ]
  • [ 371-41-5 ]
  • [ 394-33-2 ]
YieldReaction ConditionsOperation in experiment
65% With water In tetrahydrofuran at 25℃; for 2.5 h; Schlenk technique General procedure: To a Schlenk tube were added Phenol 1 (0.3 mmol), tert-Butyl nitrite 2a (0.6mmol), H2O (0.6 mmol), and THF (2 mL). Then the tube was stirred at 25 oC under airatmosphere for the indicated time until complete consumption of starting materialmonitored by TLC analysis. After the reaction was finished, the organic extracts weredried over anhydrous Na2SO4, concentrated in vacuum, and the resulting residue waspurified by silica gel column chromatography (hexane/ethyl acetate) to afford thedesired product 3.
Reference: [1] Synlett, 2017, vol. 28, # 16, p. 2153 - 2156
  • 20
  • [ 371-41-5 ]
  • [ 394-33-2 ]
  • [ 123871-59-0 ]
Reference: [1] Tetrahedron, 1989, vol. 45, # 5, p. 1299 - 1310
[2] Tetrahedron Letters, 1999, vol. 40, # 12, p. 2299 - 2302
  • 21
  • [ 371-41-5 ]
  • [ 42864-24-4 ]
  • [ 5724-56-1 ]
  • [ 394-33-2 ]
  • [ 52962-97-7 ]
  • [ 52911-59-8 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1983, p. 1003 - 1010
  • 22
  • [ 371-41-5 ]
  • [ 42864-24-4 ]
  • [ 5724-56-1 ]
  • [ 394-33-2 ]
  • [ 52962-97-7 ]
  • [ 52911-65-6 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1983, p. 1003 - 1010
  • 23
  • [ 371-41-5 ]
  • [ 7697-37-2 ]
  • [ 394-33-2 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1913, vol. 32, p. 65[2] Journal de Chimie Physique et de Physico-Chimie Biologique, 1919, vol. 17, p. 27[3] Chem. Zentralbl., 1912, vol. 83, # II, p. 1964
  • 24
  • [ 371-41-5 ]
  • [ 62433-26-5 ]
Reference: [1] Organic Letters, 2018, vol. 20, # 8, p. 2437 - 2440
  • 25
  • [ 108-95-2 ]
  • [ 371-41-5 ]
  • [ 367-12-4 ]
  • [ 28177-48-2 ]
Reference: [1] Patent: CN105753655, 2016, A, . Location in patent: Paragraph 0028; 0030; 0038; 0044-0048
  • 26
  • [ 108-95-2 ]
  • [ 371-41-5 ]
  • [ 367-12-4 ]
  • [ 367-27-1 ]
  • [ 28177-48-2 ]
Reference: [1] Patent: CN105753655, 2016, A, . Location in patent: Paragraph 0028; 0030; 0038; 0054-0058
  • 27
  • [ 371-41-5 ]
  • [ 352-67-0 ]
Reference: [1] Organic Letters, 2016, vol. 18, # 18, p. 4570 - 4573
[2] Journal of Fluorine Chemistry, 2017, vol. 203, p. 130 - 135
  • 28
  • [ 17151-47-2 ]
  • [ 96898-10-1 ]
  • [ 462-06-6 ]
  • [ 371-41-5 ]
  • [ 352-67-0 ]
Reference: [1] Journal of the American Chemical Society, 2011, vol. 133, # 34, p. 13308 - 13310
  • 29
  • [ 371-41-5 ]
  • [ 399-97-3 ]
Reference: [1] Inorganic Chemistry, 2010, vol. 49, # 23, p. 11106 - 11117
[2] International Journal of Mass Spectrometry, 2013, vol. 345-347, p. 120 - 131
  • 30
  • [ 540-36-3 ]
  • [ 371-41-5 ]
  • [ 367-27-1 ]
  • [ 2713-31-7 ]
  • [ 7664-39-3 ]
Reference: [1] Journal of the American Chemical Society, 2014, vol. 136, # 32, p. 11321 - 11330
  • 31
  • [ 371-41-5 ]
  • [ 345-16-4 ]
Reference: [1] European Journal of Organic Chemistry, 2001, # 15, p. 2911 - 2915
  • 32
  • [ 371-41-5 ]
  • [ 344-20-7 ]
  • [ 496-69-5 ]
YieldReaction ConditionsOperation in experiment
86%
Stage #1: With toluene-4-sulfonic acid In methanol for 0.166667 h;
Stage #2: With N-Bromosuccinimide In methanol for 0.416667 h;
General procedure: A solution of the starting material (~10 mmol) and pTsOH (10 mol percent) in MeOH (1.0 mL per mmol starting material) was stirred for 10 min, then a solution of NBS (100 mol percent; recrystallized from H2O) in MeOH (0.1 M) was added dropwise over 20 min from a foiled reaction flask. The reaction mixture was stirred for a further 5 min and then concentrated in vacuo. The resultant residue was purified using column chromatography (CH2Cl2, or 1percent MeOH in CH2Cl2). 3.3. Characterization of Products2-Bromo-4-methylphenol (10) [23]: 10.1 mmol; 1.73 g (92percent)
Reference: [1] Molecules, 2016, vol. 21, # 1,
  • 33
  • [ 371-41-5 ]
  • [ 496-69-5 ]
Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 2, p. 340 - 342
[2] Tetrahedron, 2010, vol. 66, # 34, p. 6906 - 6911
[3] Angewandte Chemie - International Edition, 2013, vol. 52, # 33, p. 8676 - 8680[4] Angew. Chem., 2013, vol. 125, # 33, p. 8838 - 8842,5
[5] Journal of Organic Chemistry, 2018, vol. 83, # 15, p. 7867 - 7877
[6] Journal of the American Chemical Society, 1959, vol. 81, p. 94,95, 97
[7] Bulletin of the Chemical Society of Japan, 1964, vol. 37, p. 583 - 584
[8] Patent: US4414208, 1983, A,
[9] Tetrahedron Letters, 2011, vol. 52, # 40, p. 5149 - 5152
[10] Tetrahedron, 2013, vol. 69, # 7, p. 1857 - 1871
  • 34
  • [ 371-41-5 ]
  • [ 75-36-5 ]
  • [ 394-32-1 ]
Reference: [1] Synthesis, 2007, # 8, p. 1154 - 1158
[2] Synthetic Communications, 1996, vol. 26, # 1, p. 67 - 74
[3] Journal of Medicinal Chemistry, 2007, vol. 50, # 9, p. 2108 - 2116
  • 35
  • [ 371-41-5 ]
  • [ 394-32-1 ]
Reference: [1] Synlett, 2005, # 9, p. 1465 - 1467
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 2, p. 614 - 621
[3] Pharmacy and Pharmacology Communications, 1999, vol. 5, # 5, p. 323 - 329
[4] Pharmacy and Pharmacology Communications, 1999, vol. 5, # 3, p. 189 - 193
[5] Journal of Organic Chemistry, 1951, vol. 16, p. 1345,1348
[6] Journal of the American Chemical Society, 1939, vol. 61, p. 161,164
[7] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 11, p. 2826 - 2831
[8] MedChemComm, 2013, vol. 4, # 9, p. 1257 - 1266
[9] European Journal of Medicinal Chemistry, 2015, vol. 93, p. 64 - 73
[10] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2016, vol. 55B, # 4, p. 492 - 500
  • 36
  • [ 371-41-5 ]
  • [ 64-19-7 ]
  • [ 394-32-1 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1998, # 10, p. 2678 - 2695
[2] Chemische Berichte, 1954, vol. 87, p. 194,201
  • 37
  • [ 371-41-5 ]
  • [ 106-93-4 ]
  • [ 332-48-9 ]
YieldReaction ConditionsOperation in experiment
90% With sodium hydroxide In water for 10 h; Reflux Step 2:
A 22.5percent aqueous sodium hydroxide solution (55 mL) was added to a mixture of 1,2-dibromoethane (112 g (0.60 mol)) and 4-fluorophenol (16.8 g (0.15 mol)), and the mixture was stirred 5 hours under heating at reflux.
Sodium hydroxide (3.0 g (75 mmol)) was further added thereto and the mixture was stirred for 5 hours under heating at reflux.
After completion of the reaction, the temperature was returned to room temperature, and the reaction solution was extracted three times with dichloromethane (100 mL).
The whole organic layer was dried over Na2SO4 and the solvent was distilled away under reduced pressure.
The residue was purified by a silica gel chromatography (petroleum ether: ethyl acetate = 10: 1) to obtain 1-(2-bromoethoxy)-4-fluorobenzene (compound-03) (29.7 g, 0.136 mol, yield 90percent).
Reference: [1] Patent: EP2357165, 2011, A1, . Location in patent: Page/Page column 18
[2] Bioorganic and Medicinal Chemistry Letters, 2001, vol. 11, # 4, p. 495 - 500
[3] Russian Journal of Organic Chemistry, 2000, vol. 36, # 2, p. 254 - 257
[4] Archiv der Pharmazie, 2013, vol. 346, # 3, p. 180 - 188
[5] European Journal of Medicinal Chemistry, 1992, vol. 27, # 5, p. 545 - 549
[6] Izvestiya Vysshikh Uchebnykh Zavedenii, Khimiya i Khimicheskaya Tekhnologiya, 1958, vol. 1, # 2, p. 82[7] Chem.Abstr., 1959, p. 1243
[8] Bulletin de la Societe Chimique de France, 1956, p. 185,186
[9] Journal of medicinal chemistry, 1966, vol. 9, # 2, p. 197 - 203
[10] Journal of Medicinal Chemistry, 1982, vol. 25, # 1, p. 57 - 63
[11] Central European Journal of Chemistry, 2013, vol. 11, # 11, p. 1757 - 1767
[12] European Journal of Medicinal Chemistry, 2014, vol. 81, p. 89 - 94
  • 38
  • [ 371-41-5 ]
  • [ 352-34-1 ]
  • [ 330-93-8 ]
Reference: [1] Catalysis Science and Technology, 2016, vol. 6, # 6, p. 1701 - 1709
[2] Angewandte Chemie - International Edition, 2018, vol. 57, # 14, p. 3752 - 3757[3] Angew. Chem., 2018, vol. 130, p. 3814 - 3819,6
  • 39
  • [ 371-41-5 ]
  • [ 330-93-8 ]
Reference: [1] Journal of Organic Chemistry, 2001, vol. 66, # 2, p. 633 - 634
  • 40
  • [ 371-41-5 ]
  • [ 109-70-6 ]
  • [ 1716-42-3 ]
Reference: [1] Journal of Medicinal Chemistry, 1989, vol. 32, # 1, p. 105 - 118
[2] Journal of Medicinal Chemistry, 2017, vol. 60, # 1, p. 517 - 523
[3] Indian Journal of Chemistry - Section B Organic Chemistry Including Medicinal Chemistry, 1990, vol. 29, # 1, p. 80 - 84
[4] Zhurnal Obshchei Khimii, 1959, vol. 29, p. 3708; engl. Ausg. S. 3664
  • 41
  • [ 371-41-5 ]
  • [ 142-28-9 ]
  • [ 1716-42-3 ]
Reference: [1] Angewandte Chemie - International Edition, 2015, vol. 54, # 32, p. 9347 - 9350[2] Angew. Chem., 2015, vol. 127, # 32, p. 9479 - 9482,4
[3] Angewandte Chemie - International Edition, 2016, vol. 55, # 18, p. 5550 - 5554[4] Angew. Chem., 2016, vol. 128, p. 5640 - 5644,5
  • 42
  • [ 371-41-5 ]
  • [ 13675-18-8 ]
  • [ 71597-85-8 ]
Reference: [1] Journal of the American Chemical Society, 2016, vol. 138, # 9, p. 2985 - 2988
  • 43
  • [ 371-41-5 ]
  • [ 2713-29-3 ]
YieldReaction ConditionsOperation in experiment
67.8%
Stage #1: With sodium iodide; sodium hydroxide In methanol at 0 - 10℃; for 0.25 h; Inert atmosphere
Stage #2: With sodium hypochlorite In methanol at 0 - 10℃; for 2.5 h;
To a round bottom flask, equipped with an addition funnel, and under N2 atmosphere at 0-10 °C, was added, methanol (200 mL), 4-fluorophenol (8.00 g, 71.37 mmol), Nal (12.84 g, 85.64 mmol) and NaOH (3.43 g, 85.64 mmol). This solution was allowed to stir for approximately 15 minutes, at 0-10 °C, before adding, dropwise, NaOCI (133 mL from 5percent v/v in commercial bleach, 92.77 mmol) over the period of 1.5 hours. After this bleach addition was complete, the reaction was allowed to stir for an additional hour at 0-10 °C. Next, 100 mL of 10 wtpercent aqueous sodium thiosulfate was added to the reaction mixture. The reaction mixture was then acidified with 5percent HC1, extracted into methylene chloride (500 mL), washed with 500 mL each of 10 wtpercent aqueous sodium thiosulfate, water, then brine, and then dried over anhydrous magnesium sulfate, filtered through a pad of silica gel, and then concentrated to give an oil. This crude was purified by recrystallization using hexanes, to afford 11.52 g (67.8percent) of pure compound as white crystals. 1H NMR (500 MHz, Chloroform-d) δ 7.36 (dd, J= 7.6, 2.9 Hz, 1H), 6.97 (ddd, J= 8.9, 7.7, 2.9 Hz, 2H), 6.92 (dd, J= 9.0, 4.9 Hz, 1H), 5.10 (s, 1H). 13C NMR (101 MHz, Chloroform-d) δ 156.42 (d, J= 243.0 Hz), 151.45 (d, J= 2.6 Hz), 124.34 (d, J= 25.3 Hz), 116.83 (d, J= 23.1 Hz), 115.08 (d, J= 7.8 Hz), 84.23 (d, J= 9.0 Hz). iyF NMR (376 MHz, Chloroform-d) δ -122.52 (td, J= 7.6, 4.9 Hz). MS m/e 238.
Reference: [1] Journal of the Brazilian Chemical Society, 2010, vol. 21, # 1, p. 3 - 6
[2] Chemical Communications, 2016, vol. 52, # 29, p. 5152 - 5155
[3] Organic and Biomolecular Chemistry, 2017, vol. 15, # 9, p. 1956 - 1960
[4] Patent: WO2016/89935, 2016, A1, . Location in patent: Page/Page column 27; 28
[5] Tetrahedron Letters, 2010, vol. 51, # 16, p. 2170 - 2173
[6] Synlett, 2007, # 14, p. 2227 - 2231
[7] Phosphorus, Sulfur and Silicon and the Related Elements, 2009, vol. 184, # 3, p. 651 - 659
[8] Patent: US2015/291713, 2015, A1,
[9] Chemistry Letters, 2017, vol. 46, # 5, p. 733 - 736
  • 44
  • [ 371-41-5 ]
  • [ 392-72-3 ]
  • [ 2713-29-3 ]
Reference: [1] Patent: WO2004/67529, 2004, A1, . Location in patent: Page 77 - 78
  • 45
  • [ 371-41-5 ]
  • [ 445-83-0 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1916, vol. 35, p. 142[2] Chem. Zentralbl., 1913, vol. 84, # II, p. 760
  • 46
  • [ 371-41-5 ]
  • [ 26690-80-2 ]
  • [ 263409-78-5 ]
  • [ 97308-23-1 ]
Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 27, p. 4591 - 4595
  • 47
  • [ 371-41-5 ]
  • [ 67475-56-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 8, p. 1735 - 1746
  • 48
  • [ 371-41-5 ]
  • [ 113209-68-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 310 - 317
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 1, p. 310 - 317
  • 49
  • [ 371-41-5 ]
  • [ 51446-30-1 ]
Reference: [1] European Journal of Organic Chemistry, 2001, # 15, p. 2911 - 2915
  • 50
  • [ 371-41-5 ]
  • [ 214360-58-4 ]
Reference: [1] Journal of the American Chemical Society, 2015, vol. 137, # 4, p. 1593 - 1600
  • 51
  • [ 50-00-0 ]
  • [ 371-41-5 ]
  • [ 91407-41-9 ]
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 28, p. 4443 - 4445
  • 52
  • [ 371-41-5 ]
  • [ 99199-60-7 ]
Reference: [1] Patent: CN104072470, 2016, B,
[2] Patent: CN104072470, 2016, B,
[3] Patent: CN108148032, 2018, A,
  • 53
  • [ 371-41-5 ]
  • [ 473416-33-0 ]
Reference: [1] Patent: US2012/225863, 2012, A1,
[2] Patent: WO2012/119046, 2012, A2,
  • 54
  • [ 371-41-5 ]
  • [ 84478-87-5 ]
Reference: [1] Patent: US6586368, 2003, B1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 371-41-5 ]

Fluorinated Building Blocks

Chemical Structure| 372-20-3

[ 372-20-3 ]

3-Fluorophenol

Similarity: 0.97

Chemical Structure| 75996-29-1

[ 75996-29-1 ]

5-Fluorobenzene-1,3-diol

Similarity: 0.91

Chemical Structure| 2713-34-0

[ 2713-34-0 ]

3,5-Difluorophenol

Similarity: 0.91

Chemical Structure| 367-12-4

[ 367-12-4 ]

2-Fluorophenol

Similarity: 0.91

Chemical Structure| 2713-33-9

[ 2713-33-9 ]

3,4-Difluorophenol

Similarity: 0.91

Aryls

Chemical Structure| 372-20-3

[ 372-20-3 ]

3-Fluorophenol

Similarity: 0.97

Chemical Structure| 75996-29-1

[ 75996-29-1 ]

5-Fluorobenzene-1,3-diol

Similarity: 0.91

Chemical Structure| 2713-34-0

[ 2713-34-0 ]

3,5-Difluorophenol

Similarity: 0.91

Chemical Structure| 367-12-4

[ 367-12-4 ]

2-Fluorophenol

Similarity: 0.91

Chemical Structure| 2713-33-9

[ 2713-33-9 ]

3,4-Difluorophenol

Similarity: 0.91